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Cyclosporine induces elevated procollagen o1 (I) mRNA levels in the
rat renal cortex. Chronic cyclosporine nephrotoxicity is a poorly
understood drug side-effect characterized by renal cortical interstitial
scarring. To evaluate procollagen mRNA levels as an early factor in the
development of this form of renal fibrosis, we measured renal procol-
lagen alpha 1(I), alpha 1 (III), alpha I (IV) and -actin mRNA levels in
rats treated with cyclosporine (C5A) or the olive oil vehicle (00) for
one or four weeks. Renal morphology was similar without atrophy or
fibrosis in one week CsA and 00 and four week 00 rats. Four week
CsA rats had focal cortical interstitial fibrosis and tubular atrophy.
Cortical procollagen alpha 1 (I) mRNA levels were increased in CsA
versus 00 rats at one week (P < 0.02) and four weeks (P < 0.02). One
week medullary procollagen alpha 1 (1) and all other one week medul-
lary, and one and four week cortical procollagen and /3-actin mRNA
levels were no different in CsA versus 00 rats. The early increase in
renal cortical procollagen alpha 1 (I) mRNA levels precedes renal
morphologic abnormalities, and may represent an important step in the
pathogenesis of cyclosporine-induced renal cortical fibrosis.
Chronic cyclosporine nephrotoxicity is a lesion occurring
with increasing frequency as transplant recipients are treated
with cyclosporine for long periods of time. This renal process,
encompassing cortical interstitial fibrosis and tubular atrophy,
occurs in patients with various transplanted organs including
heart [1—31, liver [41, and kidney [5—7]. Chronic nephrotoxicity
also occurs in patients receiving cyclosporine for various au-
toimmune diseases [8—10]. in humans, the renal fibrosis gener-
ally develops after at least three to six months of therapy and
can lead to renal failure and dialysis dependence. This devas-
tating side effect of cyclosporine therapy is an important
limiting factor in the use of this otherwise superior immunosup-
pressive agent [7, 11].
The mechanisms underlying cyclosporine-induced renal fi-
brosis have not been elucidated clearly. Rodent models, estab-
lished in our laboratory [121 and by others [13, 141, share
histologic features of human chronic nephrotoxicity which
include focal cortical scarring with variable mononuclear in-
flammatory infiltrates. The rat histologic lesion develops by
four weeks and provides a model for the evaluation of events
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leading to renal scarring. In this study, we measured renal
procollagen alpha 1 (I), alpha 1 (III) and alpha I (IV), and
beta-actin mRNA levels in cyclosporine-treated rodents before
and after development of the histologic changes of chronic
cyclosporine nephrotoxicity. This was done to evaluate procol-
lagen mRNA levels as a possible pathogenetic link to the
initiation of cyclosporine-induced renal scarring.
Methods
Experimental animals
Male Wistar rats (200 to 225 g, Charles Rivers Laboratories,
Wilmington, Massachusetts, USA) were injected with cyclo-
sporine 25 mg/kg/day subcutaneously (N = 8 at each time) or
with equal volumes of the olive oil vehicle (N = 8 at each time)
for either one or four weeks. All animals were given free access
to standard rat chow and water. The following measurements
were made prior to initiation of therapy and immediately prior
to sacrifice one or four weeks later: body weight, serum and
24-hour urine creatinine (Beckman autoanalyzer Ii, Irvine,
California, USA). Systolic arterial blood pressure was mea-
sured prior to sacrifice by the tail cuff method in awake
restrained animals [15]. Rats sacrificed after one week of
injections additionally had hematocrit measurements prior to,
and kidney weights measured after, sacrifice. Animals were
anesthetized with ketamine and xylazine and sacrificed; kid-
neys were removed, and processed as indicated below.
Renal histology
Portions of renal tissue were fixed in alcoholic Bouin's
solution or glutaraldehyde for light and electron microscopies,
respectively, and processed in the standard fashion [161. Par-
affin sections were stained with periodic-acid Schiff and Mas-
son's trichrome and examined in a blinded fashion. Renal
cortices were evaluated using a Zeiss light microscope and
digitizer tablet. A minimum of 15 low-power fields (10 x
objective) were measured for total cortical surface area. All foci
of tubular atrophy and interstitial fibrosis in the total cortical
surface areas measured were then evaluated to obtain the
surface area of scarring. A scarring index was expressed as the
percent of total cortical surface area containing scar. Repre-
sentative portions of renal cortex from all experimental groups
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Initial Cra/100 g body wt 0.71 0.21 0.67 0.07
Final Cra/l00 g body wt 0,56 0.06" 1.14 0.26
Blood pressure mm Hg 135 4 137 3
Weightgaing 87 4C 122 7
were examined ultrastructurally using an Hitachi liE electron
microscope.
In vitro hybridization
Manual separation of the cortex and medulla was performed
on the remainder of the kidneys. Cortical samples consisted of
the outer 1 to 1.5 mm of cortex. "Medullary" samples from
animals treated for one week were examined and included deep
renal cortex, medulla and portions of papillae. All samples were
homogenized in guanidium thiocyanate, snap frozen in liquid
nitrogen and stored at 70°C until RNA isolation was begun.
Total RNA was isolated by the guanidium thiocyanate/cesium
chloride ultracentrifugation method 11171. RNA was quantitated
by spectrophotometry at OD 260n, and the quality assessed
by measuring the 260 nM to 280 nrs'i OD ratio. Electrophoretic
analysis was performed additionally to assess quality of RNA.
Ten rg of RNA per sample were centrifuged in a speed-vac for
10 minutes and suspended in diethylprocarbonate-treated wa-
ter. A 2x gel running buffer with 2 M formaldehyde and
formamide was added, samples incubated at 55°C for 15 min-
utes, and loading buffer added. Samples were then run on a 1%
agarose gel containing ethidium bromide using horizonal elec-
trophoresis for four hours at 22°C with a constant voltage of 75
V. After completion of electrophoresis the gel was washed,
neutralized and destained overnight at 4°C and photographed
under UV illumination.
For Northern blot analysis, the gel was washed and soaked in
20 x SSC for one hour. The RNA was then transferred to a
nitrocellulose filter (Nitroplus 2000) for 24 hours at 25° using 20
x SSC as the transfer solution. After transfer, the filter was
washed in 3 x SCC for five minutes and dried at 80°C under
vacuum for one hour. Prehybridization and hybridization with
cDNA probes was then carried out as for slot blots described
below.
Messenger RNA was quantitated by placing five serial dilu-
tions of total RNA samples (10, 5, 2.5, 1.25, 0.625 g) from each
rat cortex or medulla on nitrocellulose/nylon filters (all 4 week
samples on Hybond C extra, Amersham International, Amer-
sham, UK) or nitrocellulose filters (all 1 week samples on
Nitroplus 2000, Micron Separations Inc., Westboro, Massachu-
setts, USA). Filters were vacuum baked at 80°C for two hours
and prehybridized. Filters were subsequently hybridized over-
night with either HF-677 procollagen alpha 1 (I) cDNA probe
[181 or HF-934 procollagen alpha 1 (III) cDNA probe [191 (gifts
from Dr. Juoni Uitto), a 1.8 kb procollagen alpha I (IV) cDNA
probe (a gift from Drs. R. Boot-Hanford and M. Kurkinen) or a
1.85 kb rat cDNA probe for 13-actin (a gilt from Dr. L. Keddes)
Cyclosporine
treated
1.12 0.29
Olive oil
treated
1.61 0.48Initial Cr°/l00 g body wt
Final C/100 g body wt 0.82 0.11 0.72 0.05
Blood pressure mm Hg 130 4 125 5
Weightgaing 30 4" 43 2
Hematocrit 42 1.0 44 0.7
Total kidney weight g 2.0 0.07 2.1 0.09
Kidney/body wt ratio 9.7 0.3 9.2 0.3
g X
radiolabeled with 32P (Multiprime kit, Amersham). Binding of
all specified cDNA probes to rat procollagen mRNA has
demonstrated that the probes recognize unique mRNAs [20—
23j. Hybridized filters were washed to a stringency of 0.2 x
SSC at 62° (Hybond C) or 0.5 X SCC (Nitroplus 2000) and
developed with Kodak XAR film with two Quanta III intensi-
fying screens (Eastman Kodak, Rochester, New York, USA) at
—70°C. Developed autoradiograms were quantitated by a com-
puting laser densitometer (Helena Laboratories, Beaumont,
Texas, USA). Specific procollagen alpha 1 (I), alpha 1 (III),
alpha 1 (IV) and 13-actin mRNA levels were expressed in optical
density units per 2 zg of total RNA as calculated based on linear
regressions for each experimental animal sample. Results are
expressed as the percent change in the mean procollagen or
/3-actin mRNA levels in the cyclosporine group compared to the
mean value in the olive oil control group.
Statistical analysis
Results are expressed as the mean SEM. Comparisons were
done using Student's t-test for unpaired samples; significant
results were determined by P < 0.05.
Results
Experimental animals and physiologic data
Animals treated for four weeks were studied first to docu-
ment the histologic lesions of chronic cyclosporine r!ephrotox-
icity, and to evaluate mRNA levels in rats with the renal
scarring. Animals treated for one week were then examined to
evaluate morphologic changes and mRNA levels earlier in the
development of chronic nephrotoxicity. The mean values for
creatinine clearance, blood pressure and body weight gain for
the four week study are listed in Table I. Initial endogenous
creatinine clearance was not different in the cyclosporine (CsA)
injected versus olive oil vehicle (00) injected rats. Final
creatinine clearance was significantly reduced in the CsA
compared to the 00 rats (0.56 0.06 vs. 1.14 0.26 mI/mini
100 g body wt, P <0.05; 1.51 0.18 vs. 2.00 0.14 ml/min, P
<0.05). Body weight gain was also significantly less in the CsA
(87 4 g) versus 00 (122 7 g) animals (P < 0.005).
The mean values for creatinine clearance, blood pressure,
body weight gain, kidney weight and hematocrit for the one
week treated animals are listed in Table 2. Initial endogenous
creatinine clearance and final creatinine clearance calculated as
mi/mm and as mllmin/lOO g body weight, systolic arterial blood
Table 1. Physiologic data from animals treated with cyclosporine or
olive oil for four weeks
Cyclosporine
treated
Olive oil
treated
Table 2. Physiologic data from animals treated with cyclosporine or
olive oil for one week
a Creatinine clearance (mI/mm)
' P < 0.05 vs. olive oil
P < 0.005 vs. olive oil
a Creatinine clearance (mI/mm)
"P < 0.02 vs. olive oil
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Fig. 1. Renal cortex from rats treated with cyclosporine (GsA). A. One week treatment. There are no abnormalities of the tubules, interstitium
or glomeruli. All olive oil treated animals have a similar appearance. B. Four week treatment. There is focal interstitial fibrosis with tubular atrophy
and a mild mononuclear inflammatory infiltrate. Periodic-acid Schiff x 150.
Fig. 2. Ultrastructure of proximal tubular epithelial cells from rat kidneys. A. Rat treated with cyclosporine for one week. There are enlarged
atypical mitochondna (arrow). Brush borders are normal (arrowhead) and there are no cytoplasmic isometric vacuolization or microcalcifications.
B. Animal administered olive oil for one week. The changes are similar to those in A; no isometric vacuoles or microcalcifications are evident.
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Fig. 3. Glomeruli and arterioles
from rats treated with cyclosporine.
A. After treatment for one week the
arterioles are normal. B. Four
weeks of treatment. The arterioles
have enlarged smooth muscle cells
and increased renin granules
(arrow). X 280
Table 3. Renal cortical tubulo-interstitial scarring index for treated
rats
Cyclosporine Olive oil
One week 0.01% 0.004 0.005% 0.001
Four weeks 1.41% 0.06a 0.03% 0.004
a P < 0.00001 vs. all other groups
pressure and hematocrit levels were not significantly different in
the CsA compared to 00 animals. Body weight gain was less in
the CsA (30 4 g) compared to the 00 animals (43 2 g, P <
0.02). However, kidney weights and kidney weight corrected
for body weight (CsA 9.7 0.3 vs. 00 9.2 0.3 g kidney
weight/g body weight x 10, P > 0.05) were not different in the
two groups.
Renal morphology
Kidneys from animals treated with CsA for four weeks had
significant amounts of cortical tubulo-interstitial scarring in a
"striped" pattern (4 week CsA vs. I week CsA, P < 0.00001;
Fig. 1, Table 3). There were mononuclear infiltrates in the foci
of fibrosis of four week CsA treated animals. Enlarged atypical
tubular cell mitochondria were also occasionally present; the
significance of this finding is unclear as similar changes were
found in one week CsA and all 00 treated animals (Fig. 2). No
cytoplasmic isometric vacuolization was observed in tubular
epithelium of four week CsA animals. Juxtaglomerular appara-
tus and arteriolar smooth muscle cells were enlarged and
contained many renin granules in the four week CsA animals
(Fig. 3). In contrast, the animals treated with 00 for both one
and four weeks and CsA for one week had few individual
atrophic tubules with scant interstitial fibrosis (Fig. 1, Table 3).
Tubular epithelial cells were normal or contained atypical
mitochondria (Fig. 2); there was no cytoplasmic isometric
vacuolization. There were rare scattered interstitial mononu-
clear inflammatory infiltrates in the cortices of one week CsA,
and one and four week 00 treated animals. Juxtaglomerular
apparatus were normal in these three groups. Brush borders
were intact in nonatrophic proximal tubules from all groups.
There were no abnormalities of the medullary region in this
model with either treatment at either time.
Fig. 4. Northern analyses of renal cortical total RNA. A. Procollagen
alpha 1 (I) mRNA has two distinct bands at 4.8 and 5,8 Kb. B.
Beta-actin mRNA has one distinct band at 1.2 Kb.
In vitro hybridizations
Formaldehyde gel electrophoresis, revealing clear 28S and
l8S RNA bands in all samples, demonstrated that the RNA was
intact. Northern analysis of renal cortical total RNA hybridized
with procollagen alpha 1 (I) eDNA probe revealed specificity
for a unique mRNA with two bands at 4.8 and 5.8 Kb as
described for the probe HF-667 [21] (Fig. 4). Northern analysis
utilizing procollagen alpha I (III) eDNA probe demonstrated
two bands at 4.8 and 5.4 Kb [21], while procollagen alpha 1 (IV)
eDNA hybridization resulted in four bands, two above 6.0 Kb
and two below 4.6 Kb [20, 22]. Beta-actin eDNA probe hybrid-
ization to a single mRNA at approximately 1.2 Kb [23] (Fig. 4).
Renal cortices from animals treated for one and four weeks
and medulla from one week animals were assessed by slot blot
for procollagen alpha I (I), alpha 1 (III) and alpha 1 (IV) mRNA
levels. Beta-actin mRNA levels were evaluated as a control
probe (Fig. 5). Rats administered CsA for four weeks had mean
cortical procollagen alpha 1 (I) levels which were significantly
elevated compared to the 00 controls (CsA 163 16% of mean
00 control; P <0.02; Fig. 6). Similarly, animals given CsA for
one week had almost twice the mean procollagen alpha 1 (I)
mRNA levels (193 32% of mean control, P < 0.02) as did the
00 treated rats. There was no statistical difference between the
51-0
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Renal procollagen alpha 1 (I) mRNA
Fig. 6. Renal procollagen alpha 1(I) mRNA levels in rats treated with
cyclosporine (LI) or olive oil (R) for I or 4 weeks. Cyclosporine treated
rats have significant elevations in cortical mRNA levels at 1 and 4
weeks. There is no difference in the medullary mRNA levels.
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Fig. 5. Slot blots of RNA extracted from
kidneys of rats treated with cyclosporine
(CsA) or olive oil (00) for one week. A.
Procollagen alpha 1 (I) mRNA. The CsA
treated animal has more binding of probe than
the 00 treated animal. B. Beta-actin mRNA.
There is no difference in the degree of binding
between the CsA and 00 treated rats.
procollagen alpha I (I) mRNA levels in the animals adminis-
tered cyclosporine for one or four weeks. In contrast, medul-
lary procollagen alpha 1 (I) mRNA levels from one week
animals were no different in 00 and CsA (91 10% of mean
control, P > 0.05) treated animals. Mean cortical procollagen
alpha 1 (III) mRNA levels were no different in animals treated
with CsA for four weeks (134 25% of mean control, P > 0.05)
or one week (111 19% of mean control, P >0.05; Fig. 7). One
week medullary procollagen alpha 1 (III) mRNA levels were
similar in CsA (93 7% of mean control) and 00 animals (Fig.
7). Procollagen alpha 1 (IV) mRNA levels were not significantly
different in the one week or four week CsA versus 00 animals
in the cortex (161 54% and 158 33% of mean control,
respectively) or in the one week medullary samples (Fig. 8).
Beta-actin mRNA levels were similar in cortex and medulla
from all animals in all locations at the times studied (Fig. 9).
Discussion
Renal cortical focal or "striped" interstitial fibrosis with
tubular atrophy characterize the morphologic changes observed
in chronic cyclosporine nephrotoxicity in animals and man
[1—14]. Renal interstitial fibrosis primarily consists of types I
and III collagen whereas tubular basement membrane contains
predominantly type IV collagen [24]. Therefore, we sought to
evaluate early alterations in levels of renal procollagen alpha 1
(I), alpha 1(111), and alpha 1 (IV) mRNA as a possible indicator
of the initial development of scarring in chronic cyclosporine
nephrotoxicity. In this study, rats treated with cyclosporine or
its vehicle for one or four weeks were assessed for renal
morphologic changes and procollagen and beta-actin mRNA
levels. Histologic study revealed the renal tubulo-interstitial
scarring of chronic cyclosporine nephrotoxicity only in the
cortex of animals treated with cyclosporine for four weeks; no
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Fig. 7. Renal procollagen alpha I (III) mRNA levels in rats treated
with cyclosporine (LI) or olive oil (R) for I or 4 weeks. There are no
differences at either time in any of the groups or locations.
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Fig. S. Renal procollagen alpha I (IV) mRNA levels in rats treated
with cyclosporirze (EJ) or olive oil (R) for I or 4 weeks. There are no
significant differences in any group at either time.
fibrosis was observed in the cortex of the one week cyclospor-
me group, any vehicle treated animals or in the medullary
regions. In vitro hybridization demonstrated specific elevations
of procollagen alpha 1 (I) mRNA levels in the cortex of
cyclosporine treated rats at both one and four weeks. No
significant increases in medullary alpha I (I) mRNA or in
cortical or medullary procollagen alpha I (III), alpha 1 (IV) or
beta-actin mRNA levels were detected at the times studied.
The morphologic changes observed in kidneys of the rats
treated with cyclosporine for four weeks are similar to those
described by other investigators [13, 14]. Animals administered
cyclosporine for one week lacked histologic features of chronic
nephrotoxicity. The one week animals also lacked the morpho-
logic characteristics of acute nephrotoxicity, including tubular
epithelial cytoplasmic isometric vacuolization, brush border
simplification, or microcalcification [251. Additionally, creati-
nine clearance was not reduced at the completion of the one
week study, further suggesting the absence of acute severe
nephrotoxic injury. Despite the apparent lack of acute or
chronic renal damage after only one week of cyclosporine
administration, procollagen alpha 1(I) mRNA levels in the renal
cortex were almost double those of controls. This suggests that
there are events related to cyclosporine use which stimulate
elevations of procollagen alpha I (I) mRNA levels in the renal
cortex very early in the course of therapy.
The specific increases in procollagen alpha I (I) mRNA
levels, which are limited to the renal cortex, represent biochem-
ical changes induced by cyclosporine. These alterations in
mRNA levels could be related to increases in procollagen gene
expression or decreases in mRNA degradation; in either case,
the increased procollagen mRNA levels are likely related to the
pathogenesis of cyclosporine associated renal cortical scarring.
The mechanisms by which cyclosporine induces this site- and
procollagen-specific increase in mRNA levels could involve
renal ischemia, direct cyclosporine action on tubular cells or
fibroblasts, andlor cytokine-mediated stimulation. Cyclospôr-
me reduces renal plasma flow, stimulates the renin-angiotensin
axis and produces functional renal ischemia in the rat [26—291.
The overall effect of these changes could be ischeinia-induced
Renal )3-actin mRNA
Fig. 9. Renal beta-actin mRNA levels in rats treated with cyclosporine(U) or olive oil (R) for I or 4 weeks. No significant differences are
present among the groups at 1 or 4 weeks.
changes in renal cortical cell(s) resulting in enhanced procolla-
gen alpha 1 (I) mRNA levels. Direct action of cyclosporine on
tubular cells or fibroblasts also could be responsible for the
specific elevation of procollagen mRNA levels. Cyclosporine
itself has other direct actions on tubular cells, altering protein
metabolism [301 and reducing mitochondrial respiration [311.
Alternatively, cyclosporine could produce its effect secondarily
via up- or down-regulation of cytokine production. Cyclospor-
me alters lymphokine production and macrophage function
[32—35], and is associated with focal renal cortical mononuclear
inflammatory cell infiltrates [25]. These potential mechanisms
could work independently or in concert to increase procollagen
alpha 1 (I) mRNA levels in the renal cortex.
In this study, the increase in cyclosporine induced procolla-
gen alpha 1 (I) mRNA levels has been localized to the renal
cortex. However, the specific cell types responsible for this
increase remain to be determined. Renal interstitial fibroblasts
may be an important factor in the early increases in procollagen
alpha I (I) mRNA levels. Fibroblasts elaborate predominantly
types I and III collagen [36], may also produce type IV collagen
[371, and are activated early in cyclosporine treatment [38].
Alternatively, tubular epithelial cells could be involved in this
process as both tubular atrophy and interstitial fibrosis are
components of chronic cyclosporine nephrotoxicity. Tubular
cells produce predominantly type IV collagen [24] although
they have been reported also to produce type I collagen in vitro
[39]. Therefore, fibroblasts and/or tubular cells may be involved
in the early cyclosporine-associated increase in procollagen
alpha 1 (I) mRNA levels. Alternatively, a decrease in mRNA
degradation could be responsible for the increased mRNA
levels without specific cell stimulation.
This study has demonstrated an early specific increase in
renal cortical procollagen alpha 1 (I) mRNA levels in rats
treated with cyclosporine for one or four weeks. This increase
preceded renal morphologic scarring after one week of cyclo-
sporine administration and persisted when changes of chronic
nephrotoxicity were observed after four weeks of treatment.
The specific cell types involved, and the roles of increased
procollagen gene expression or decreased mRNA degradation
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as factors increasing mRNA levels have yet to be determined.
The findings in this study do show, however, that chronic
cyclosporine nephrotoxicity is associated with increased levels
of cortical procollagen alpha 1 (I) mRNA levels, which may be
the result of an acquired dysregulation of interstitial collagen
gene transcription. This may be an important step in the
pathway leading to cyclosporine-induced renal cortical scar-
ring. The effectiveness of translation and ultimate production of
renal cortical collagens require further investigation.
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